Pulmonary Hypertension Trial, Recruiting NCT06871293 Sponsor: Fundación Cardioinfantil Instituto de Cardiología Condition: Pulmonary Hypertension
Back to Pulmonary Hypertension

Pulmonary Hypertension Trial, Recruiting

NCT06871293
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have had a confirmed COVID-19 diagnosis.
  • You had high blood pressure or diabetes before being registered in the study's participating hospitals or before your COVID-19 diagnosis.
  • You have had two or more symptoms related to long COVID that have lasted for at least 4 weeks (symptoms may be constant or come and go).
  • At least one of your ongoing symptoms affects your ability to carry out daily activities — these can be physical symptoms (such as tiredness, shortness of breath, muscle or joint pain) or mental/emotional symptoms (such as memory problems, sleep difficulties, or mood changes).
  • Your symptoms are not better explained by another illness or condition you had before or alongside your COVID-19 infection.
  • You are able to read and participate in rehabilitation sessions focused on physical and cognitive (thinking and memory) recovery, or receive health information messages.

Who may not be able to join:

  • You are older than 80 years of age.
  • You had serious, advanced health conditions before your COVID-19 infection.
  • You have a chronic lung disease requiring extra oxygen, significant heart failure, or advanced kidney disease (confirm with trial site).
  • You were hospitalised twice in the year before joining the study due to a pre-existing health condition.
  • You rely on a caregiver to help you with daily activities.
  • You have bone, joint, or heart/lung problems that make aerobic exercise (such as walking or cycling) unsafe for you.
  • You have neurological, psychiatric, or cognitive difficulties that prevent you from understanding instructions or completing attention and thinking exercises.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +6016672727

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Fundación Cardioinfantil Instituto de Cardiología
Registry
ClinicalTrials.gov
Start date
30 October 2025
Est. completion
31 December 2026

Where this trial is recruiting

🇨🇴 Colombia

Primary endpoints

Composite Change in Functional Capacity, Cognitive Function, Health-Related Quality of Life, and Strength

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov